EDWARD GRAVISS to Kaplan-Meier Estimate
This is a "connection" page, showing publications EDWARD GRAVISS has written about Kaplan-Meier Estimate.
Connection Strength
0.186
-
Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG. Am J Pathol. 2021 01; 191(1):90-107.
Score: 0.037
-
Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomes. Sci Rep. 2019 12 27; 9(1):20168.
Score: 0.035
-
Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series. Lancet Gastroenterol Hepatol. 2018 05; 3(5):337-348.
Score: 0.031
-
Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation. Clin Transplant. 2017 08; 31(8).
Score: 0.030
-
The detrimental impact of persistent vs an isolated occurrence of de novo donor-specific antibodies on intermediate-term renal transplant outcomes. Clin Transplant. 2017 08; 31(8).
Score: 0.030
-
Intermediate-term graft loss after renal transplantation is associated with both donor-specific antibody and acute rejection. Transplantation. 2014 Mar 15; 97(5):534-40.
Score: 0.024